Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_assertion type Assertion NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_head.
- NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_provenance.
- NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_assertion evidence source_evidence_literature NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_provenance.
- NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_assertion SIO_000772 23861247 NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_provenance.
- NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_assertion wasDerivedFrom befree-20150227 NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_provenance.
- NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_assertion wasGeneratedBy ECO_0000203 NP217818.RASDGv15XTAgMQPqz6EZlt7m15dRBJr-EOqFDC93uuC9k130_provenance.